BioCorRx (BICX) Return on Sales (2011 - 2026)

BioCorRx (BICX) has 16 years of Return on Sales data on file, last reported at 0.04% in Q1 2026.

• Quarterly Return on Sales rose 2.0% year-over-year to 0.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06% (up 29.0% YoY) and the FY2025 annual result came in at 0.04%, up 676.0% from the prior year.
• Return on Sales grew to 0.04% in Q1 2026 per BICX's latest filing, from 0.09% in the prior quarter.
• The five-year high for Return on Sales was 0.02% in Q3 2025, with the low at 6.8% in Q4 2024.
• Average Return on Sales over 5 years is 1.12%, with a median of 0.46% recorded in 2022.
• Year-over-year, Return on Sales sank 629 bps in 2024 and jumped 671 bps in 2025.
• BioCorRx's Return on Sales stood at 0.14% in 2022, then plunged by 266 bps to 0.51% in 2023, then slumped by 1229 bps to 6.8% in 2024, then surged by 99 bps to 0.09% in 2025, then surged by 57 bps to 0.04% in 2026.
• Business Quant data shows BICX's Return on Sales at 0.04% in Q1 2026, 0.09% in Q4 2025, and 0.02% in Q3 2025.